 | • レポートコード：GIR-107A14720 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、リスペリドンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。リスペリドンの種類別市場規模（経口、注射可能）、用途別市場規模（統合失調症、双極性障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・リスペリドンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Janssen Pharmaceutica、Teva、Sun Pharmaceutical、Aurobindo、Cipla、Invent Farma Group、Medichem、Interquim、IPCA、RPG、Sharon、Torrent Pharmaceuticals、Temad、Wuxi Jida、Changzhou Siyao Pharmaceuticals、Ningbo Team Pharm、Zhejiang Huahai Pharmaceutical、TIPR、Qilu Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射可能 ・用途別分析2016年-2026年：統合失調症、双極性障害 ・リスペリドンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リスペリドンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リスペリドンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リスペリドンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リスペリドンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Risperidone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Risperidone size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Risperidone market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Risperidone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injectable
Market segment by Application can be divided into
Schizophrenia
Bipolar Disorder
The key market players for global Risperidone market are listed below:
Janssen Pharmaceutica
Teva
Sun Pharmaceutical
Aurobindo
Cipla
Invent Farma Group
Medichem
Interquim
IPCA
RPG
Sharon
Torrent Pharmaceuticals
Temad
Wuxi Jida
Changzhou Siyao Pharmaceuticals
Ningbo Team Pharm
Zhejiang Huahai Pharmaceutical
TIPR
Qilu Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Risperidone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Risperidone, with price, sales, revenue and global market share of Risperidone from 2019 to 2021.
Chapter 3, the Risperidone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Risperidone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Risperidone market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Risperidone sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Risperidone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Risperidone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Risperidone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.4 Global Risperidone Market Size & Forecast
1.4.1 Global Risperidone Sales in Value (2016-2026))
1.4.2 Global Risperidone Sales in Volume (2016-2026)
1.4.3 Global Risperidone Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Risperidone Production Capacity Analysis
1.5.1 Global Risperidone Total Production Capacity (2016-2026)
1.5.2 Global Risperidone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Risperidone Market Drivers
1.6.2 Risperidone Market Restraints
1.6.3 Risperidone Trends Analysis
2 Manufacturers Profiles
2.1 Janssen Pharmaceutica
2.1.1 Janssen Pharmaceutica Details
2.1.2 Janssen Pharmaceutica Major Business
2.1.3 Janssen Pharmaceutica Risperidone Product and Services
2.1.4 Janssen Pharmaceutica Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Risperidone Product and Services
2.2.4 Teva Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business
2.3.3 Sun Pharmaceutical Risperidone Product and Services
2.3.4 Sun Pharmaceutical Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aurobindo
2.4.1 Aurobindo Details
2.4.2 Aurobindo Major Business
2.4.3 Aurobindo Risperidone Product and Services
2.4.4 Aurobindo Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Risperidone Product and Services
2.5.4 Cipla Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Invent Farma Group
2.6.1 Invent Farma Group Details
2.6.2 Invent Farma Group Major Business
2.6.3 Invent Farma Group Risperidone Product and Services
2.6.4 Invent Farma Group Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Medichem
2.7.1 Medichem Details
2.7.2 Medichem Major Business
2.7.3 Medichem Risperidone Product and Services
2.7.4 Medichem Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Interquim
2.8.1 Interquim Details
2.8.2 Interquim Major Business
2.8.3 Interquim Risperidone Product and Services
2.8.4 Interquim Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 IPCA
2.9.1 IPCA Details
2.9.2 IPCA Major Business
2.9.3 IPCA Risperidone Product and Services
2.9.4 IPCA Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 RPG
2.10.1 RPG Details
2.10.2 RPG Major Business
2.10.3 RPG Risperidone Product and Services
2.10.4 RPG Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sharon
2.11.1 Sharon Details
2.11.2 Sharon Major Business
2.11.3 Sharon Risperidone Product and Services
2.11.4 Sharon Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Torrent Pharmaceuticals
2.12.1 Torrent Pharmaceuticals Details
2.12.2 Torrent Pharmaceuticals Major Business
2.12.3 Torrent Pharmaceuticals Risperidone Product and Services
2.12.4 Torrent Pharmaceuticals Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Temad
2.13.1 Temad Details
2.13.2 Temad Major Business
2.13.3 Temad Risperidone Product and Services
2.13.4 Temad Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Wuxi Jida
2.14.1 Wuxi Jida Details
2.14.2 Wuxi Jida Major Business
2.14.3 Wuxi Jida Risperidone Product and Services
2.14.4 Wuxi Jida Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Changzhou Siyao Pharmaceuticals
2.15.1 Changzhou Siyao Pharmaceuticals Details
2.15.2 Changzhou Siyao Pharmaceuticals Major Business
2.15.3 Changzhou Siyao Pharmaceuticals Risperidone Product and Services
2.15.4 Changzhou Siyao Pharmaceuticals Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Ningbo Team Pharm
2.16.1 Ningbo Team Pharm Details
2.16.2 Ningbo Team Pharm Major Business
2.16.3 Ningbo Team Pharm Risperidone Product and Services
2.16.4 Ningbo Team Pharm Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Zhejiang Huahai Pharmaceutical
2.17.1 Zhejiang Huahai Pharmaceutical Details
2.17.2 Zhejiang Huahai Pharmaceutical Major Business
2.17.3 Zhejiang Huahai Pharmaceutical Risperidone Product and Services
2.17.4 Zhejiang Huahai Pharmaceutical Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 TIPR
2.18.1 TIPR Details
2.18.2 TIPR Major Business
2.18.3 TIPR Risperidone Product and Services
2.18.4 TIPR Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Qilu Pharmaceutical
2.19.1 Qilu Pharmaceutical Details
2.19.2 Qilu Pharmaceutical Major Business
2.19.3 Qilu Pharmaceutical Risperidone Product and Services
2.19.4 Qilu Pharmaceutical Risperidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Risperidone Sales by Manufacturer
3.1 Global Risperidone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Risperidone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Risperidone
3.4 Market Concentration Rate
3.4.1 Top 3 Risperidone Manufacturer Market Share
3.4.2 Top 6 Risperidone Manufacturer Market Share
3.5 Global Risperidone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Risperidone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Risperidone Market Size by Region
4.1.1 Global Risperidone Sales in Volume by Region (2016-2026)
4.1.2 Global Risperidone Revenue by Region (2016-2026)
4.2 North America Risperidone Revenue (2016-2026)
4.3 Europe Risperidone Revenue (2016-2026)
4.4 Asia-Pacific Risperidone Revenue (2016-2026)
4.5 South America Risperidone Revenue (2016-2026)
4.6 Middle East and Africa Risperidone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Risperidone Sales in Volume by Type (2016-2026)
5.2 Global Risperidone Revenue by Type (2016-2026)
5.3 Global Risperidone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Risperidone Sales in Volume by Application (2016-2026)
6.2 Global Risperidone Revenue by Application (2016-2026)
6.3 Global Risperidone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Risperidone Sales by Type (2016-2026)
7.2 North America Risperidone Sales by Application (2016-2026)
7.3 North America Risperidone Market Size by Country
7.3.1 North America Risperidone Sales in Volume by Country (2016-2026)
7.3.2 North America Risperidone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Risperidone Sales by Type (2016-2026)
8.2 Europe Risperidone Sales by Application (2016-2026)
8.3 Europe Risperidone Market Size by Country
8.3.1 Europe Risperidone Sales in Volume by Country (2016-2026)
8.3.2 Europe Risperidone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Risperidone Sales by Type (2016-2026)
9.2 Asia-Pacific Risperidone Sales by Application (2016-2026)
9.3 Asia-Pacific Risperidone Market Size by Region
9.3.1 Asia-Pacific Risperidone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Risperidone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Risperidone Sales by Type (2016-2026)
10.2 South America Risperidone Sales by Application (2016-2026)
10.3 South America Risperidone Market Size by Country
10.3.1 South America Risperidone Sales in Volume by Country (2016-2026)
10.3.2 South America Risperidone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Risperidone Sales by Type (2016-2026)
11.2 Middle East & Africa Risperidone Sales by Application (2016-2026)
11.3 Middle East & Africa Risperidone Market Size by Country
11.3.1 Middle East & Africa Risperidone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Risperidone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Risperidone Typical Distributors
12.3 Risperidone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Risperidone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Risperidone Revenue by Application, (USD Million), 2021-2026
Table 3. Janssen Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Pharmaceutica Major Business
Table 5. Janssen Pharmaceutica Risperidone Product and Services
Table 6. Janssen Pharmaceutica Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Risperidone Product and Services
Table 10. Teva Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharmaceutical Major Business
Table 13. Sun Pharmaceutical Risperidone Product and Services
Table 14. Sun Pharmaceutical Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Major Business
Table 17. Aurobindo Risperidone Product and Services
Table 18. Aurobindo Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Risperidone Product and Services
Table 22. Cipla Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Invent Farma Group Basic Information, Manufacturing Base and Competitors
Table 24. Invent Farma Group Major Business
Table 25. Invent Farma Group Risperidone Product and Services
Table 26. Invent Farma Group Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Medichem Basic Information, Manufacturing Base and Competitors
Table 28. Medichem Major Business
Table 29. Medichem Risperidone Product and Services
Table 30. Medichem Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Interquim Basic Information, Manufacturing Base and Competitors
Table 32. Interquim Major Business
Table 33. Interquim Risperidone Product and Services
Table 34. Interquim Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. IPCA Basic Information, Manufacturing Base and Competitors
Table 36. IPCA Major Business
Table 37. IPCA Risperidone Product and Services
Table 38. IPCA Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. RPG Basic Information, Manufacturing Base and Competitors
Table 40. RPG Major Business
Table 41. RPG Risperidone Product and Services
Table 42. RPG Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sharon Basic Information, Manufacturing Base and Competitors
Table 44. Sharon Major Business
Table 45. Sharon Risperidone Product and Services
Table 46. Sharon Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Torrent Pharmaceuticals Major Business
Table 49. Torrent Pharmaceuticals Risperidone Product and Services
Table 50. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Temad Basic Information, Manufacturing Base and Competitors
Table 52. Temad Major Business
Table 53. Temad Risperidone Product and Services
Table 54. Temad Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Wuxi Jida Basic Information, Manufacturing Base and Competitors
Table 56. Wuxi Jida Major Business
Table 57. Wuxi Jida Risperidone Product and Services
Table 58. Wuxi Jida Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Changzhou Siyao Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Changzhou Siyao Pharmaceuticals Major Business
Table 61. Changzhou Siyao Pharmaceuticals Risperidone Product and Services
Table 62. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Ningbo Team Pharm Basic Information, Manufacturing Base and Competitors
Table 64. Ningbo Team Pharm Major Business
Table 65. Ningbo Team Pharm Risperidone Product and Services
Table 66. Ningbo Team Pharm Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Zhejiang Huahai Pharmaceutical Major Business
Table 69. Zhejiang Huahai Pharmaceutical Risperidone Product and Services
Table 70. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. TIPR Basic Information, Manufacturing Base and Competitors
Table 72. TIPR Major Business
Table 73. TIPR Risperidone Product and Services
Table 74. TIPR Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Qilu Pharmaceutical Major Business
Table 77. Qilu Pharmaceutical Risperidone Product and Services
Table 78. Qilu Pharmaceutical Risperidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Risperidone Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 80. Global Risperidone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Risperidone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Risperidone Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 83. Head Office and Risperidone Production Site of Key Manufacturer
Table 84. Risperidone New Entrant and Capacity Expansion Plans
Table 85. Risperidone Mergers & Acquisitions in the Past Five Years
Table 86. Global Risperidone Sales by Region (2016-2021e) & (K Pcs)
Table 87. Global Risperidone Sales by Region (2021-2026) & (K Pcs)
Table 88. Global Risperidone Revenue by Region (2016-2021e) & (USD Million)
Table 89. Global Risperidone Revenue by Region (2021-2026) & (USD Million)
Table 90. Global Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 91. Global Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 92. Global Risperidone Revenue by Type (2016-2021e) & (USD Million)
Table 93. Global Risperidone Revenue by Type (2021-2026) & (USD Million)
Table 94. Global Risperidone Price by Type (2016-2021e) & (USD/Pcs)
Table 95. Global Risperidone Price by Type (2021-2026) & (USD/Pcs)
Table 96. Global Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 97. Global Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 98. Global Risperidone Revenue by Application (2016-2021e) & (USD Million)
Table 99. Global Risperidone Revenue by Application (2021-2026) & (USD Million)
Table 100. Global Risperidone Price by Application (2016-2021e) & (USD/Pcs)
Table 101. Global Risperidone Price by Application (2021-2026) & (USD/Pcs)
Table 102. North America Risperidone Sales by Country (2016-2021e) & (K Pcs)
Table 103. North America Risperidone Sales by Country (2021-2026) & (K Pcs)
Table 104. North America Risperidone Revenue by Country (2016-2021e) & (USD Million)
Table 105. North America Risperidone Revenue by Country (2021-2026) & (USD Million)
Table 106. North America Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 107. North America Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 108. North America Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 109. North America Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 110. Europe Risperidone Sales by Country (2016-2021e) & (K Pcs)
Table 111. Europe Risperidone Sales by Country (2021-2026) & (K Pcs)
Table 112. Europe Risperidone Revenue by Country (2016-2021e) & (USD Million)
Table 113. Europe Risperidone Revenue by Country (2021-2026) & (USD Million)
Table 114. Europe Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 115. Europe Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 116. Europe Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 117. Europe Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 118. Asia-Pacific Risperidone Sales by Region (2016-2021e) & (K Pcs)
Table 119. Asia-Pacific Risperidone Sales by Region (2021-2026) & (K Pcs)
Table 120. Asia-Pacific Risperidone Revenue by Region (2016-2021e) & (USD Million)
Table 121. Asia-Pacific Risperidone Revenue by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 123. Asia-Pacific Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 124. Asia-Pacific Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 125. Asia-Pacific Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 126. South America Risperidone Sales by Country (2016-2021e) & (K Pcs)
Table 127. South America Risperidone Sales by Country (2021-2026) & (K Pcs)
Table 128. South America Risperidone Revenue by Country (2016-2021e) & (USD Million)
Table 129. South America Risperidone Revenue by Country (2021-2026) & (USD Million)
Table 130. South America Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 131. South America Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 132. South America Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 133. South America Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 134. Middle East & Africa Risperidone Sales by Country (2016-2021e) & (K Pcs)
Table 135. Middle East & Africa Risperidone Sales by Country (2021-2026) & (K Pcs)
Table 136. Middle East & Africa Risperidone Revenue by Country (2016-2021e) & (USD Million)
Table 137. Middle East & Africa Risperidone Revenue by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Risperidone Sales by Type (2016-2021e) & (K Pcs)
Table 139. Middle East & Africa Risperidone Sales by Type (2021-2026) & (K Pcs)
Table 140. Middle East & Africa Risperidone Sales by Application (2016-2021e) & (K Pcs)
Table 141. Middle East & Africa Risperidone Sales by Application (2021-2026) & (K Pcs)
Table 142. Direct Channel Pros & Cons
Table 143. Indirect Channel Pros & Cons
Table 144. Risperidone Typical Distributors
Table 145. Risperidone Typical Customers
List of Figures
Figure 1. Risperidone Picture
Figure 2. Global Risperidone Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injectable
Figure 5. Global Risperidone Sales Market Share by Application in 2020
Figure 6. Schizophrenia
Figure 7. Bipolar Disorder
Figure 8. Global Risperidone Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 9. Global Risperidone Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Risperidone Sales (2016-2026) & (K Pcs)
Figure 11. Global Risperidone Price by Type (2016-2026) & (USD/Pcs)
Figure 12. Global Risperidone Production Capacity (2016-2026) & (K Pcs)
Figure 13. Global Risperidone Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Risperidone Market Drivers
Figure 15. Risperidone Market Restraints
Figure 16. Risperidone Market Trends
Figure 17. Global Risperidone Sales Market Share by Manufacturer in 2020
Figure 18. Global Risperidone Revenue Market Share by Manufacturer in 2020
Figure 19. Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Risperidone Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Risperidone Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Risperidone Sales Market Share by Region (2016-2026)
Figure 23. Global Risperidone Revenue Market Share by Region (2016-2026)
Figure 24. North America Risperidone Revenue (2016-2026) & (USD Million)
Figure 25. Europe Risperidone Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Risperidone Revenue (2016-2026) & (USD Million)
Figure 27. South America Risperidone Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Risperidone Revenue (2016-2026) & (USD Million)
Figure 29. Global Risperidone Sales Market Share by Type (2016-2026)
Figure 30. Global Risperidone Revenue Market Share by Type (2016-2026)
Figure 31. Global Risperidone Price by Type (2016-2026) & (USD/Pcs)
Figure 32. Global Risperidone Sales Market Share by Application (2016-2026)
Figure 33. Global Risperidone Revenue Market Share by Application (2016-2026)
Figure 34. Global Risperidone Price by Application (2016-2026) & (USD/Pcs)
Figure 35. North America Risperidone Sales Market Share by Type (2016-2026)
Figure 36. North America Risperidone Sales Market Share by Application (2016-2026)
Figure 37. North America Risperidone Sales Market Share by Country (2016-2026)
Figure 38. North America Risperidone Revenue Market Share by Country (2016-2026)
Figure 39. United States Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Risperidone Sales Market Share by Type (2016-2026)
Figure 43. Europe Risperidone Sales Market Share by Application (2016-2026)
Figure 44. Europe Risperidone Sales Market Share by Country (2016-2026)
Figure 45. Europe Risperidone Revenue Market Share by Country (2016-2026)
Figure 46. Germany Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Risperidone Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Risperidone Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Risperidone Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Risperidone Revenue Market Share by Region (2016-2026)
Figure 55. China Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Risperidone Sales Market Share by Type (2016-2026)
Figure 62. South America Risperidone Sales Market Share by Application (2016-2026)
Figure 63. South America Risperidone Sales Market Share by Country (2016-2026)
Figure 64. South America Risperidone Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Risperidone Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Risperidone Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Risperidone Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Risperidone Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Risperidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
双極性障害治療薬の世界市場… Scope of the Report: The worldwide market for Bipolar Disorder Therapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Bip…- 世界のニードルポイントバイポーライオン化市場 2021：企業別、地域別、種類・用途別 The Needlepoint Bipolar Ionization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の自閉症スペクトラム障害診断市場 2021：企業別、地域別、種類・用途別 The Autism Spectrum Disorder Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Musculoskeletal Disorder Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の色素脱失障害治療市場 2021：企業別、地域別、種類・用途別 The Hypopigmentation Disorder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…